The study defines a new neuroscientific paradigm (synergistic model), which allows to better understand the complexity of the interactions between brain, body and environment and paves the way to ...

Mouse analog of MICVO (maMICVO) monotherapy produced dose-dependent inhibition of tumor growth in a syngeneic preclinical model of HNSCC maMICVO monotherapy modulated the tumor-immune environment in a ...